The use of D-ribose in chronic fatigue syndrome and fibromyalgia: A pilot study

Journal of Alternative and Complementary Medicine

Volumn 12, Issue 9, 2006, Pages 857-862

  Teitelbaum, Jacob E ^a,c   Johnson, Clarence ^b   St Cyr, John ^b  

^a Fibromyalgia and Fatigue Centers   (United States)

^b Valen Labs   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE DERIVATIVE; CORVALEN; PENTOSE; RIBOSE;

ADULT; ANXIETY DISORDER; ARTICLE; CELL ENERGY; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; DIZZINESS; DRUG TOLERABILITY; ENERGY METABOLISM; FEMALE; FIBROMYALGIA; HEART MUSCLE; HUMAN; INCREASED APPETITE; MALE; MENTAL FUNCTION; NAUSEA; PILOT STUDY; PRIORITY JOURNAL; QUESTIONNAIRE; SKELETAL MUSCLE; SLEEP; SYMPTOMATOLOGY; TREATMENT OUTCOME; VISUAL ANALOG SCALE; WELLBEING;

ACTIVITIES OF DAILY LIVING; ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; FATIGUE SYNDROME, CHRONIC; FEMALE; FIBROMYALGIA; HUMANS; MIDDLE AGED; PAIN MEASUREMENT; PATIENT SATISFACTION; PILOT PROJECTS; QUALITY OF LIFE; QUESTIONNAIRES; RIBOSE; TREATMENT OUTCOME;

EID: 33751102106     PISSN: 10755535     EISSN: None     Source Type: Journal    
DOI: 10.1089/acm.2006.12.857     Document Type: Article

References (26)

1. Goldenberg DL. Fibromyalgia syndrome-an emerging but controversial condition. JAMA 1987;257:2782-2787.
2. Wolfe F, Ross K, Anderson J, et al. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheumatol 1995;38:19-28.
3. Travell JG, Simons DG. Myofascial Pain and Dysfunction: The Trigger Point Manual, vol. 1. Baltimore: Williams & Wilkins, 1983.
4. Peckerman A, LaMancha JJ, Dahl KA, et al. Abnormal impedance cardiography predicts symptom severity in chronic fatigue syndrome. Am J Med Sci 2003;26:55-60.
5. Teitelbaum JE, Bird B, Greenfield RM, et al. Effective treatment of CFS and FMS: A randomized, double-blind placebo controlled study. J Chronic Fatigue Syndrome 2001;8:3-24.
6. Bengtson A, Heriksson KG, Larsson J. Reduced high-energy phosphate levels in the painful muscles of patients with primary fibromyalgia. Arthritis Rheumatol 1986;29:817-821.
7. Eisinger J, Plantamura A, Ayavou T. Glycolysis abnormalities in fibromyalgia. J Am Coll Nutr 1994;13:144-148.
8. Omran H, Illien S, MacCarter D, et al. D-Ribose improves diastolic function and quality of life in congestive heart failure patients: A prospective feasibility study. Eur J Heart Failure 2003;5:615-619.
9. Hellsten Y, Skadgauge L, Bangsbo J. Effect of ribose supplementation on resynthesis of adenine nucleotides after intense intermittent training in humans. Am J Physiol 2004;286:R182-R188.
10. Gebhart B, Jorgenson J. Benefit of ribose in a patient with fibromyalgia. Pharmacotherapy 2004;24:1646-1648.
11. Lund N, Bengtsson A, Thorborg P. Muscle tissue oxygen in primary fibromyalgia. Scan J Rheumatol 1986;15:165-173.
12. Schachter CL, Busch AL, Peloso PM, Shepard MS. Effects of short versus long bouts of aerobic exercise in sedentary women with fibromyalgia: A randomized controlled trial. Phys Ther 2003;83:340-358.
13. Lund E, Kendall SA, Janerot-Sjoberg B, Bengtsson A. Muscle metabolism in fibromyalgia studied by P-31 magnetic resonance spectroscopy during aerobic and anaerobic exercise. Scand J Rheumatol 2003;32:138-145.
14. Strobl ES, Krapf M, Suckfull M, et al. Tissue oxygen measurement and 31P magnetic resonance spectroscopy in patients with muscle tension and fibromyalgia. Rheumatol Int 1997;16:175-180.
15. Krapf MW, Muller S, Mennet P, et al. Recording muscle spasms in the erector spinae using in vivo 31P magnetic resonance spectroscopy in patients with chronic lumbalgia and generalized tendomyopathies. Z Rheumatol 1992;51:229-237.
16. Park JH, Phothimat P, Oates CT, et al. Use of P-31 magnetic resonance spectroscopy to detect metabolic abnormalities in muscles of patients with fibromyalgia. Arthritis Rheumatol 1998;41:406-413.
17. Jacobsen S, Jensen KE, Thomsen C, et al. Magnetic resonance spectroscopy in fibromyalgia. A study of phosphate-31 spectra from skeletal muscles during rest and after exercise. Ugeskr Laeger 1994;156:6841-6844.
18. Kushmerick MJ. Muscle energy metabolism, nuclear magnetic resonance spectroscopy and their potential in the study of fibromyalgia. J Rheumatol 1989;(Suppl 19):40-46.
19. Sprott H, Rzanny R, Reichenbach JR, et al. 31P magnetic resonance spectroscopy in fibromyalgic muscle. Rheumatology (Oxford) 2000;39:1121-1125.
20. Brault JJ, Terjung RL. Purine salvage to adenine nucleotides in different skeletal muscle fiber types. J Appl Physiol 2001;91:231-238.
21. Tullson PC, Terjung RL. Adenine nucleotide synthesis in exercising and endurance-trained skeletal muscle. Am J Physiol 1991;261:C342-C347.
22. Reibel D, Rovetto M. Myocardial ATP synthesis and mechanical function following oxygen deficiency. Am J Physiol. 1978;234:H620-H624.
23. Williamson DL, Gallagher PM, Goddard MP, Trappe SW. Effects of ribose supplementation on adenine nucleotide concentration in skeletal muscle following high-intensity exercise. Med Sci Sport Exc 2001;33(5 suppl):5166.
24. Olson NJ, Park JH. Skeletal muscle abnormalities in patients with fibromyalgia. Am J Med Sci 1998;315:351-358.
25. Eisinger J, Bagneres D, Arroyo P, et al. Effects of magnesium, high-energy phosphates, piracetam and thiamin on erythrocyte transketolase. Magnet Res 1994;7:59-61.
26. Bengtsson A, Henriksson KG. The muscle in fibromyalgia - a review of Swedish studies. J Rheumatol Suppl 1989;19:144-149.